Lars Fruergaard Jørgensen CEO of Novo Nordisk
“I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug. The production team on this episode were PLAN-B’s Niklas…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from In Good Company with Nicolai Tangen
See all episodes →
43%Venki Ramakrishnan: The Science and Hype of Living Longer
41%Eliot Higgins: How Bellingcat Hunts Down the Truth
39%Horizon Robotics CEO: Car Chips, Mind-Off Driving and China's Speed
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.